Bachelor's at Chemical Engineering from University of Sao Paulo (2014), specialized in Biotechnology from Centre of Post-Graduation Oswaldo Cruz and Master in Sciences (Farmacology) by the Biomedical Sciences Institute at University of Sao Paulo. Currently, undergoes his PhD studies in Molecular Biology in the Biochemistry Department of the Federal University of Sao Paulo. His research is focused on surface glycoproteins that are linked in high grade astrocytoma tumorigenesis. He has experience in the chemical processes, having worked in "Liquigas Distribuidora S.A." and developed a modelling project of adsorption in particulated beds; and in LSCP of the Engineering School of University of Sao Paulo, in a degradation study of antibiotics derived from fluoroquinolones by the photo-Fenton process and by solar reactor employment. Moreover, he has already developed softwares for manipulation of Input-Output matrices and acted in projects headed by the Foundation Institute of Economical Researches (FIPE). In 2016 was conceded a scholarship by the Massachussets Institute of Technology (MIT) to attend the "Controlled Release Technology: Delivery Systems for Pharmaceuticals" course directed by professor Robert Langer; and in 2017 his Master's work, focused on Central Nervous System homing-nanocarriers, led to a First Prize in the "Roberto Melaragno Filho e Antonio Spina-França Neto" Prize at the XI Paulista Neurology Congress.
Possui graduação em Engenharia Química pela Universidade de São Paulo (2014), especialização em Biotecnologia no Centro de Pós-Graduação Oswaldo Cruz (2016), Mestrado em Ciências, área de Farmacologia (ICB-USP, 2017), e Doutorado em Biologia Molecular (UNIFESP, 2019). Realizou dois estágios pós-doutorais na University of Alabama at Birmingham, um com foco em tumores ginecológicos sob supervisão da Dr. Mythreye Karthykeyan, e outro em doenças neuropsiquiátricas com a Dr. Qin Wang. Foi é pesquisador, nível V, na mesma Universidade, tendo como foco a pesquisa translacional, imunoterapia dos gliomas. Tem domínio em ferramentas de bioinformática (bulk-RNAseq, scRNAseq, ATAC-seq ou versões multimodais), nos imunoensaios, e nas técnicas de integração in vitro, in vivo, ex vivo e análise de pacientes. Foi condecorado com diversos prêmios, como Travel Awards pelo MIT (2016) e pelo Weizmann Institute of Science (2019), dois prêmios por desempenho pós-doutoral (2020), e por seus trabalhos (2017, 2021).
